Quinolone resistance inPseudomonas aeruginosa andStaphylococcus aureus. Development during therapy and clinical significance
Author:
- 1 March 1994
- journal article
- review article
- Published by Springer Nature in Infection
- Vol. 22 (2) , S111-S121
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Molecular epidemiology ofPseudomonas aeruginosain an intensive care unitEpidemiology and Infection, 1993
- Ciprofloxacin-resistant methicillin-sensitive Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1993
- Activity of amoxycillin clavulanic/acid against Escherickia coli in vivoJournal of Antimicrobial Chemotherapy, 1992
- Fluoroquinolones in the treatment of cystic fibrosis: A critical appraisalEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Use of a ribosomal RNA gene probe for the epidemiological study of methicillin and ciprofloxacin resistantStaphylococcus aureusEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiencyJournal of Antimicrobial Chemotherapy, 1990
- Methicillin-Resistant Staphylococcus aureusNew England Journal of Medicine, 1989
- The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivoJournal of Antimicrobial Chemotherapy, 1987
- Ciprofloxacin, azlocilin, ceftizoxime and amikacin alone and in combination against Gram-negative bacilli in an infected chamber modelJournal of Antimicrobial Chemotherapy, 1986
- Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumoniaJournal of Antimicrobial Chemotherapy, 1985